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Granzyme B-Induced Apoptosis Requires
Both Direct Caspase Activation
and Relief of Caspase Inhibition
it induces a death program that results in the destruction
of the pathogenic cell.
The enzymatic activity of grB is the key to its ability to
induce cell death. It is a member of the serine proteinase
family with an unusual specificity to cleave substrates
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1Department of Biochemistry at aspartic acid residues (Odake et al., 1991). The first
substrate to be identified for grB was the cysteine prote-University of Alberta
Edmonton, Alberta T6G 2H7 ase, caspase 3 (Darmon et al., 1995; Quan et al., 1996).
This caspase plays a central role in the effector stage2 Children’s Hospital of Eastern Ontario
Research Institute of apoptosis in a wide variety of systems. The activation
of caspase 3 by grB is a two-step process. Cleavage401 Smyth Road, Room 308
Ottawa K1H 8L1 occurs at aspartate 175, resulting in the production of
fragments p20 and p10. The larger subunit is then pro-Canada
cessed to p19/17 by the self-catalytic activity of the
caspase (Martin et al., 1996), resulting in a fully active
dimer composed of p17 and p10. Once activated, ma-
Summary ture caspase 3 acts on a number of substrates that
are responsible for the biochemical and morphological
Cytotoxic lymphocytes employ Granzyme B as a po- features of apoptosis.
tent initiator of apoptosis to cleave and activate ef- In numerous apoptotic systems, mitochondria also
fector caspases. Unexpectedly, cells transfected with play a pivotal role. Recent evidence has suggested that
Bcl-2 were resistant to granzyme B-induced killing, these organelles are also involved in the grB pathway
suggesting that a mitochondrial pathway was critical. (Heibein et al., 1999; MacDonald et al., 1999). Both mito-
Utilizing cells expressing a dominant-negative cas- chondrial depolarization and cytochrome c leakage oc-
pase 9, the current study demonstrated that caspase cur in CTL-mediated lysis. Most importantly, these pro-
activation via the apoptosome was not required. In- ceed in a caspase-independent fashion, suggesting that
deed, cleavage of caspase 3 to p20 still occurred in other grB substrates are involved. Recently, it has been
Bcl-2-transfectants but processing to p17 was blocked. shown that grB can cleave and activate the proapoptotic
This blockade was recapitulated by the Inhibitor- member of the Bcl-2 family, Bid (Barry et al., 2000).
of-Apoptosis-Protein XIAP and relieved by Smac/ Granzyme-truncated bid (gtBid) has a different amino
DIABLO. Thus granzyme B mediates direct cleavage of terminus than the caspase 8 cleaved form (tBid), but
caspase 3 and also activates mitochondrial disruption, both translocate to the mitochondria in association with
resulting in the release of proapoptotic proteins that Bax to bring about cytochrome c release (Heibein et al.,
suppress caspase inhibition. Engagement of both 2000; Sutton et al., 2000). The rate of Bid cleavage by
pathways is critical for granzyme-induced killing. grB is faster than grB-mediated caspase 3 activation
(Pinkoski et al., 2001). This has led to the hypothesis
that the physiologically relevant route to active caspaseIntroduction
3 proceeded primarily through Bid, mitochondrial cyto-
chrome c release, and caspase 9 activation throughCytotoxic T lymphocytes (CTL) and Natural Killer (NK)
formation of the apoptosome (Jiang and Wang, 2000).cells utilize two pathways to activate target cell death;
Caspase activity is regulated not only by control ofFas and perforin/granzyme. Apoptosis mediated by Fas
zymogen activation as stated above, but also via directis required for lymphocyte homeostasis, whereas granu-
inhibition of active caspases by Inhibitor of Apoptosislar killing is important for the control of viral infections,
Proteins (IAPs). IAPs were originally described in bacu-tumor surveillance, and transplant rejection (Barry and
lovirus (Crook et al., 1993), although multiple mammalianBleackley, 2002; Russell and Ley, 2002). Granzymes A
family members have now been identified (Duckett etand B are the major effector molecules of granular-
al., 1996; Liston et al., 1996; Rothe et al., 1995; Uren etmediated killing and initiate distinct pathways to target
al., 1996). The best-characterized IAP to date is XIAP.cell apoptosis (Beresford et al., 1999; Shresta et al.,
This protein can directly bind and inhibit the processed1999). Granzyme B (grB) is responsible for rapid induc-
forms of caspases 3, 7, and 9 (Chai et al., 2001; Huangtion of cell death (Heusel et al., 1994; Shresta et al.,
et al., 2001; Riedl et al., 2001; Srinivasula et al., 2001),1995). CTLs and NK cells store granzymes in cyto-
thus preventing cleavage of downstream substrates.plasmic granules that are vectorally exocytosed toward
Furthermore, the inhibitory activity of IAPs is modulateda target such as a virus infected or tumor cell. GrB is
by other proteins that are released from mitochondriathen taken up by receptor-mediated endocytosis into
along with cytochrome c, including Smac/DIABLO (Ver-the cytoplasm of the target (Motyka et al., 2000) where
hagen et al., 2000) and Omi/HtrA2 (Hegde et al., 2002;
Martins et al., 2002; Suzuki et al., 2001; Verhagen et*Correspondence: chris.bleackley@ualberta.ca
al., 2002). Thus, when these proteins are liberated from3 Present address: Department of Medical Microbiology and Immu-
nology, University of Alberta, Edmonton, Alberta T6G 2S2, Canada. mitochondria, they bind tightly to IAPs and release the
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suppression on caspase activity (Chai et al., 2000; Liu
et al., 2000; Wu et al., 2000).
In this report, we present evidence for a novel two-
step regulatory mechanism for grB activation of caspase
3. The pathway depends on the action of grB on both
the effector caspase and Bid and involves the release
of proteins from mitochondria other than cytochrome c.
Results
Cells Overexpressing Bcl-2 Are Protected
from Granzyme B-Induced Cell Death
In order to activate a target cell’s apoptotic program, the
serine protease grB cleaves many cytosolic substrates,
among which are the death-inducing caspases (Barry
and Bleackley, 2002; Trapani, 2001). In addition, cells
undergoing grB-mediated apoptosis display mitochon-
drial disruption such as cytochrome c release and loss
of membrane potential (Heibein et al., 1999; MacDonald
et al., 1999). To understand the functional relevance of
the mitochondrial events, we investigated whether the
antiapoptotic protein Bcl-2 influenced grB-induced cell
death.
Jurkat clones overexpressing Bcl-2 (J-Bcl-2) were
generated and tested for sensitivity to activation of apo-
ptosis. As expected, these clones were protected from
various apoptosis-inducing regimes such as death re-
ceptor ligation (Fas/CD95/Apo-1), or activation of the
intrinsic pathway with agents such as staurosporine
(data not shown). Bcl-2-transfected cells were exposed
to grB in the presence of replication-deficient adenovi-
rus (AD). AD functioned, like the granular pore-forming
protein perforin, to facilitate the release of grB into the
target cell (Froelich et al., 1996). These GrB/AD-treated
Bcl-2-transfected cells were resistant to apoptosis (Fig-
ure 1). After incubation with grB/AD, 53% of the control Figure 1. Bcl-2 Expression Protects Cells from GrB/AD-Mediated
Cell DeathJurkat-neo (J-neo) cells displayed DNA fragmentation
DNA fragmentation as assessed by TUNEL and tritium releaseas assessed by TUNEL, whereas J-Bcl-2 cells displayed
assays.only 0.3% cell death (Figure 1A). Similar results were
(A) 106 Jurkat (J), Jurkat-neo (J-neo), or Jurkat-Bcl-2 (J-Bcl-2) cellsobtained with grB and perforin. Utilizing the tritium re-
were treated with 600 ng/ml of granzyme B and adenovirus at an
lease assay, which measures the production of small moi of 100 for 2 hr at 37C. Cells were fixed and then processed
DNA fragments, J-neo cells treated for 2 hr with grB/ for the TUNEL reaction. Percent specific TUNEL positive cells was
calculated by Fluorescence Activated Cell Sorting analysis as de-AD produced 72% tritium release, versus 0.1% tritium
scribed in Experimental Procedures. Data are the mean  SD offrom J-Bcl-2 cells (Figure 1B). In addition, J-Bcl-2 cells
five independent experiments.treated with grB/AD had minimal membrane damage
(B) J, J-neo, and J-Bcl-2 cells were labeled with 3H-thymidine over-
as assessed by 51Cr-release (data not shown). Multiple night and then treated with grB/AD as above. Percent specific 3H-
independent Bcl-2 transfected clones were analyzed, thymidine release was calculated as described in Experimental Pro-
cedures.and all exhibited resistance to the induction of apoptosis
by granzyme B. Over a longer time frame (24 hr), the
J-Bcl-2-expressing cells did display DNA fragmentation,
possibly mediated via a caspase-independent route, al- Granzyme B Can Bypass the Protective Effect
though there was no apparent cytolysis as assessed by of Dominant-Negative Caspase 9
51Cr release. Additionally, we assessed other cell targets The first mitochondrial apoptotic pathway to be fully
that are not dependent on the mitochondrial pathway elucidated was the assembly of the apoptosome, a
for Fas-mediated cell death, such as SKW6.4 Type I multisubunit complex comprised of mitochondrial-
cells (Scaffidi et al., 1998), and determined that Bcl-2 released cytochrome c, Apaf-1, caspase 9, and dATP/
also protected these cells from grB-mediated cell death ATP (Li et al., 1997; Liu et al., 1996; Zou et al., 1997).
(data not shown). These results all suggest that a Bcl- Given the Bcl-2 inhibition described above, it might be
2-sensitive pathway, likely mitochondria, was indeed expected that activation of the apoptosome was impor-
necessary for the full execution of grB-mediated cell tant to the grB pathway. In order to test this hypothesis,
Jurkat clones overexpressing a dominant-negative ver-death.
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trast, lysates from the J-DN-C9 cells had a significantly
reduced amount of LEHD-ase activity, indicating that
the overexpression of the dominant-negative protein did
indeed attenuate the enzymatic activity of the wild-type
protein. The J-DN-C9 cells expressed wild-type levels
of Fas, procaspase 8, FADD, Bax, and Bid and also
showed resistance to UV-mediated apoptosis (data not
shown), suggesting that these cells were able to over-
come Fas-dependent killing due to the ablation of cas-
pase 9 activity and not due to secondary mutations of
the Fas pathway.
The J-DN-C9 clones were then tested for sensitivity
to apoptosis triggered by grB. Cells were exposed to
grB/AD and assessed for DNA fragmentation and cas-
pase 3 cleavage (Figure 3). The percent of TUNEL-posi-
tive grB-treated Jurkat cells (27%) was similar to that
observed with grB-treated J-DN-C9 cells (26%), al-
though the level was slightly reduced relative to J-neo
cells (44%) (Figure 3A). Similarly, the production of small
DNA fragments as assessed by the detection of
3H-thymidine released from grB-treated cells was 77%
by J-neo cells and 60% by J-DN-C9 cells (Figure 3B).
Membrane damage of grB-treated cells was also mea-
sured by the release of 51Cr from labeled cells, and again,
J-DN-C9 and control cells displayed similar levels (data
not shown). These results contrast with those seen with
anti-Fas antibody treatment. Anti-Fas was able to induce
apoptosis of J-neo cells (59% TUNEL positive, 64% 3H-
thymidine release), whereas the J-DN-C9 cells were
largely resistant (6% TUNEL positive, 0% 3H-thymidine
release). The caspase 3 cleavage profiles of the cells
was assessed by Western blotting of cellular proteins
from untreated, grB-, or anti-Fas-treated cells. As can
be seen in Figure 3C, treatment of J-neo cells with grB/
AD produced the mature caspase 3 cleavage products,
p19/17 (Figure 3C, compare lanes 1 and 2). The same
pattern was seen in grB-treated J-DN-C9 cells (Figure
3C, lane 8). In contrast, anti-Fas treated J-DN-C9 cells
showed no caspase 3 processing (Figure 3C, lane 9).
Figure 2. DN-C9 Expression Protects Cells from Fas Oligomeriza- Therefore, although the presence of a dominant-nega-
tion-Induced Apoptosis
tive caspase 9 molecule in cells inhibited death via the
(A) Level of DN-C9 expression. Western blot analysis of J-neo or
Fas pathway, those same cells were not protected fromJ-DN-C9 lysates. The epitope-tagged DN-caspase 9, which was of
grB-mediated apoptosis.slower mobility than the endogenous caspase 9, was visualized by
immunoblotting with anti-caspase 9 antibody.
(B) Caspase 9 activity assay. J, J-neo, and J-DN-C9 clones were Caspase 3 Processing Is Blocked at p20
treated with () or without () anti-Fas antibody (250 ng/ml) for 8 in Bcl-2 Overexpressing Cells
hr prior to lysis. Cell lysates were incubated with the caspase 4-,
Since grB has been shown to directly cleave caspase5-, and 9-specific colorimetric substrate, Ac-LEHD-pNA, for 2–3 hr,
3 (Atkinson et al., 1998; Darmon et al., 1995), inhibitionand Ac-LEHD-ase activity was measured at 405 nm. Data are the
of apoptosis by Bcl-2 was unexpected. A somewhatmean  SD of three independent experiments.
surprising observation was made when we analyzed the
caspase 3 cleavage profile of grB/AD-treated J-Bcl-2
cells. Even though these cells did not die (see Figuresion of caspase 9 (C287A) (Li et al., 1997) were estab-
lished. 1), procaspase 3 was partially processed to the p20
large subunit. As seen in Figure 4A, treatment of J-neoWe characterized the Jurkat dominant-negative cas-
pase 9 (J-DN-C9) cell lines with respect to protein ex- cells with grB/AD resulted in the appearance of the
smaller fragments of processed caspase 3 (p20 andpression and caspase 9 catalytic activity. In an analysis
of total cell protein, the amount of dominant-negative p19/17) (Figure 4, lanes 2 and 3). Cells that overex-
pressed Bcl-2, however, produced only the p20 frag-protein greatly exceeded that of the barely detectable
endogenous procaspase 9 protein (Figure 2A). When ment, albeit in lower amounts, and showed no further
processing of caspase 3 to p19/17 (Figure 4, lanes 5control cells were exposed to Fas antibody, the cell
lysates displayed a considerable amount of caspase 9 and 6). Similar results were obtained with grB and per-
forin. The level of caspase 3 enzymatic activity in lysatescatalytic activity as assessed by the cleavage of the
peptide substrate Ac-LEHD-pNA (Figure 2B). In con- from treated cells was measured using Ac-DEVD-pNA.
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Figure 3. Granzyme B Can Mediate Cell Death in J-DN-C9 Cells
DNA fragmentation as assessed by TUNEL assay.
(A) J, J-neo, or J-DN-C9 cells were left untreated (open bars) or treated with grB/AD (gray bars) or anti-Fas antibody (black bars). The percent
positive TUNEL cells is graphed as the mean  SD of three independent experiments.
(B) J, J-neo, or J-DN-C9 cells were treated with grB/AD (gray bars) or anti-Fas antibody (black bars). Percent specific 3H-thymidine release
is graphed as the mean  SD of three independent experiments.
(C) Western blot analysis of J, J-neo, and J-DN-C9 cells that were untreated () or treated with 600 ng/ml grB/AD (grB) or 250 ng/ml anti-
Fas (Fas). The membranes were blotted with anti-caspase 3 antibody. The full-length procaspase 3 and processed p19 and p17 fragments
are indicated with arrows. The experiment was performed on three separate occasions and produced similar results.
Caspase activity assays revealed a significantly reduced The effect of XIAP on grB-induced death was therefore
evaluated. Initially, this was tested in an in vitro grB-amount of DEVD-ase activity in J-Bcl-2 cells (Figure
4B). Presence of the p20 fragment of caspase 3 in grB- dependent caspase 3 cleavage assay. HeLa cell lysates
treated J-Bcl-2 cells correlated with a lack of enzymatic (S100) were treated with increasing amounts of purified
activity. Therefore, cells treated with grB/AD were sus- grB in the presence of either exogenously added GST
ceptible to initial procaspase 3 processing, but high control protein, or GST-XIAP, and then the endogenous
levels of Bcl-2 prevented subsequent maturation and caspase 3 was visualized by Western blot (Figure 5A).
activation of the caspase. GrB addition resulted in the cleavage of caspase 3 to
p20 and p19 (Figure 5A, lanes 1–3). Caspase 3 was not
further processed to p17, suggesting the requirementXIAP Overexpression Can Protect Cells
of other factors not present in the in vitro system. Never-from grB-Mediated Cell Death
theless, caspase 3 was enzymatically active as as-The observation that grB-treated Bcl-2 overexpressing
sessed by activity assay. When GST-XIAP was addedcells were unable to completely process caspase 3 sug-
to the reaction, however, processing of caspase 3 wasgested that inhibitor molecules might be responsible for
arrested at the p20 fragment (Figure 5A, lane 9). Additionthe arrest of caspase 3 maturation. Such IAPs have been
of GST as a control did not inhibit caspase 3 cleavageimplicated in the regulation of caspases 3, 7, and 9
(Holcik and Korneluk, 2001; Salvesen and Duckett, 2002). (Figure 5A, compare lanes 3 and 6). These results clearly
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vented the formation of the p19 fragment of caspase 3
(Figure 5C, compare caspase 3 pattern of XIAP-express-
ing cells in lane 4 with LacZ-expressing control cells in
lane 6). This caspase 3 cleavage pattern was similar
to that of grB-treated J-Bcl-2 cells. Furthermore, these
XIAP-expressing cells were protected from grB-medi-
ated cell death as determined by TUNEL. Figure 5D is
a representative histogram of TUNEL results depicting
the inhibition of DNA fragmentation in cells expressing
XIAP (1% TUNEL positive), compared to cells express-
ing LacZ (63% TUNEL positive). Similar results were
seen in 3H-thymidine release assays (data not shown).
Therefore, overexpression of XIAP arrests the apoptotic
program initiated by grB, and this occurs via a block in
caspase 3 activation.
Smac/DIABLO Can Relieve XIAP Suppression
of Procaspase 3 Proteolytic Cleavage
Recent studies have identified a number of proteins, in
addition to cytochrome c, that are released from the
mitochondria of apoptotic cells. In particular, Smac/DIA-
BLO (Du et al., 2000; Verhagen et al., 2000) and Omi/
HtrA2 (Hegde et al., 2002; Martins et al., 2002; Suzuki
et al., 2001; Verhagen et al., 2002) have been shown to
counter the inhibitory effects of XIAP. Given the mito-
chondrial involvement in the granzyme pathway, it is
possible these molecules are involved in this system.
First, the release of Smac/DIABLO in grB-treated cells
was monitored. Untreated cells or grB/AD-treated cells
were lysed with digitonin, and the cytosolic fractions
which were depleted of mitochondria were analyzed.
Western blot analysis showed the presence of Smac/
DIABLO in the cytosol from grB-treated cells, but little
cytosolic Smac/DIABLO from non-treated cells (Figure
6A). This Smac/DIABLO release from mitochondria cor-
related with full activation of grB-cleaved caspase 3.
In order to test whether Smac/DIABLO could indeed
counter the negative effects of XIAP with respect to
Figure 4. Bcl-2 Prevents grB-Mediated Activation of Caspase 3 grB-mediated apoptosis, we again utilized the in vitro
system. Peptides generated from the amino-terminal(A) Western blot. J-neo cells (lanes 1–3) or J-Bcl-2 cells (lanes 4–6)
were mock treated (lanes 1 and 4) or treated with grB/AD for 1 hr amino acids of mature Smac/DIABLO have been shown
(lanes 2 and 5) or 2 hr (lanes 3 and 6). Cell lysates were separated to promote XIAP-suppressed caspase activation (Srini-
on SDS-PAGE, and the membranes were blotted with anti-caspase vasula et al., 2000). Therefore, we added Smac/DIABLO
3 antibody. The full-length procaspase 3 and processed p20, p19,
peptide to the granzyme-dependent caspase activationand p17 fragments are indicated with arrows.
assay described earlier. In the presence of GST control(B) Caspase 3 activity assay. J, J-neo, and J-Bcl-2 cells were treated
protein, purified grB was capable of initiating maturationwith () or without () 600 ng/ml grB/AD for 3 hr prior to lysis. Cell
lysates were incubated with the caspase 3- and 7-specific colori- of caspase 3 in S100 lysates (Figure 6B, compare lanes
metric substrate, DEVD-pNA, for 2 hr, and DEVD-ase activity was 1 and 4). When GST-XIAP was incubated with grB and
measured at 405 nm. Data are the mean  SD of three independent S100, caspase 3 cleavage was blocked at p20 (Figure
experiments.
6B, lane 6). The addition of Smac/DIABLO peptide, how-
ever, relieved the XIAP-mediated inhibition of caspase
3 processing (Figure 6B, lane 7). In these reactions, thedemonstrated that XIAP could indeed block grB-depen-
dent caspase 3 maturation but does not, in itself, directly p19 fragment was again produced. Therefore, in vitro,
the XIAP-mediated block in full caspase 3 maturationinhibit grB activity.
In order to determine in vivo whether the presence of could be overcome by the amino terminus of mature
Smac/DIABLO.XIAP would affect the apoptotic ability of grB, we utilized
an adenoviral expression system to overexpress XIAP This led to the testable hypothesis that the presence
of cytosolic Smac/DIABLO in live cells could overcomein HeLa cells. Infection with Adeno-XIAP resulted in a
significant increase in the amount of XIAP protein as the Bcl-2 block of grB-mediated death. Using an in vivo
system, we transfected HeLa cells with plasmids drivingassessed by Western blotting (Figure 5B, compare lanes
2 and 3). When these cells were then treated with grB/ the expression of Bcl-2 and either GFP alone, or a GFP-
IETD-Smac fusion construct (Srinivasula et al., 2000).AD and assayed by Western blot for caspase 3 cleavage
products, the presence of excess XIAP in the cells pre- The mature N terminus of Smac/DIABLO would remain
Immunity
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Figure 5. XIAP Overexpression Protects Cells from grB-Mediated Cell Death
(A) In vitro caspase 3 activation assay. 30 g of HeLa S100 was incubated with 20 g/ml purified GST (lanes 4–6) or 20 g/ml purified GST-
XIAP (lanes 7–9) in the presence of 0.3 g/ml (lanes 2, 5, and 8) or 3 g/ml (lanes 3, 6, and 9) granzyme B at 37C for 30 min. Reaction
products were separated on SDS-PAGE, and the membranes were blotted with anti-caspase 3 antibody. The full-length procaspase 3 and
processed p20 and p19 fragments are indicated with arrows. The experiment was performed on four separate occasions and produced similar
results.
(B) XIAP expression levels. HeLa cells were infected with adeno-XIAP (lane 2) or adeno-LacZ (lane 3) at a moi of 1, for 48 hr. Cell lysate
products were separated on SDS-PAGE, and the membranes were blotted with anti-XIAP antibody. The XIAP product is indicated with an
arrow.
(C) Cells were infected with adeno-XIAP (lanes 3–4) or adeno-LacZ (lanes 5–6) as described in (B). After a 48 hr incubation, the cells were
mock treated (lanes 1, 3, and 5) or treated with 600 ng/ml GrB/AD (lanes 2, 4, and 6) as described in Experimental Procedures. Reaction
products were separated on SDS-PAGE, and the membranes were blotted with anti-caspase 3 antibody. The full-length procaspase 3 and
processed p20, p19, and p17 fragments are indicated with arrows. The experiment was performed on four separate occasions and produced
similar results.
(D) TUNEL assay. Cells were infected with adeno-XIAP or adeno-LacZ as described in (B). After a 48 hr incubation, the cells were mock
treated () or treated with 600 ng/ml grB/AD () as described in Experimental Procedures. The cells were then fixed and processed for
TUNEL. The experiment was performed on three separate occasions and produced similar results.
blocked by GFP unless the IETD recognition site was transfected HeLa cells, the presence of Bcl-2 protected
cells from grB-mediated cell death; however, this pro-cleaved by granzyme B or by activated caspase 8 (Barry
et al., 2000). These cells were then treated with grB/ tection was reversed in the presence of cytosolic Smac/
DIABLO. Similar results were obtained with grB and per-AD, and the morphology of the GFP-positive cells was
analyzed by microscopy. As seen in Figure 6C, in the forin.
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Discussion
In the model for death induced by CTL, GrB is transferred
from the effector to the target where its ability to proteo-
lytically activate caspase 3 provides a potent apoptotic
stimulus. However, the ability of Bcl-2 to inhibit the grB
pathway (Figure 1) was a confounding finding but has
been seen in other reports (MacDonald et al., 1999; Pin-
koski et al., 2001; Sutton et al., 1997). The realization
that grB also induced a mitochondrial death program
(Heibein et al., 1999; MacDonald et al., 1999) that was
inhibited by Bcl-2 provided a plausible explanation for
the dilemma.
GrB cleaves the proapoptotic protein Bid to form
gtBid (Barry et al., 2000). The production of gtBid caused
the translocation of the proapoptotic protein Bax to mi-
tochondria (Heibein et al., 2000) and induced release of
cytochrome c (Alimonti et al., 2001; Heibein et al., 2000;
Thomas et al., 2001) and activation of caspase 9 and
then 3 (Li et al., 1997). Bak has also been implicated by
the demonstration that Bak-deficient cells are resistant
to grB-mediated cytochrome c release (Wang et al.,
2001). Bcl-2 did not inhibit Bid cleavage (Heibein et al.,
2000; Sutton et al., 2000) but aborted the translocation
step, thus thwarting cytochrome c release (Heibein et
al., 2000). Bcl-2 expression would result in no transloca-
tion of cytochrome c and consequently attenuation of
apoptosome formation and caspase 9 activation. Thus
no caspase amplification cycle could occur and apopto-
sis would be blocked.
This model predicted that caspase 9 activity was re-
quired for the granzyme pathway, but this is controver-
sial. Studies utilizing caspase 9/ cells pointed to the
importance of caspase 9 (Alimonti et al., 2001). However,
the observations that caspase 9 was cleaved relatively
late during grB-induced apoptosis (Sutton et al., 2000)
and that inhibition of apoptosome formation did not
affect the ability of grB to activate caspases in vitro
(Bruey et al., 2000), suggested that the apoptosome
was not absolutely required. Here, we used a dominant-
negative caspase 9 construct transfected into Jurkat to
address this issue. We showed, by analysis of both
caspase 3 processing and DNA fragmentation, that grB
killing was unaffected by the presence of the DN-C9,
whereas the Fas pathway was subverted. In all probabil-
ity though, assembly of a functional apoptosome does
accelerate the pathway, as the presence of the DN-C9Figure 6. Smac/DIABLO Can Relieve XIAP or Bcl-2 Inhibition of grB-
did slightly inhibit death (see Figure 3).Mediated Caspase 3 Cleavage
An important clue came from analysis of the caspase(A) Jurkat cells were mock treated (lane 1) or treated with grB/AD
3 activation profile in control and Bcl-2 transfected cells(lane 2) for 4 hr prior to lysis in buffer A sucrose  digitonin. The
cytosolic fractions devoid of mitochondria were separated on SDS- (Figure 4). Whereas empty vector transfected Jurkat
PAGE, and the membranes were blotted with anti-Smac/DIABLO cells revealed a normal pattern of caspase fragments
antibody. Location of Smac/DIABLO is indicated by an arrow. with a majority of p19, the Bcl-2-expressing cells
(B) In vitro caspase 3 cleavage assay. HeLa S100 lysates were
showed a build-up of p20. It appeared that the initialtreated with 3 g/ml grB (lanes 2–7) in the presence of 20 g/ml
cleavage event by grB was normal but the “self-cata-GST or 20 g/ml GST-XIAP with (lanes 3, 5, and 7) or without (lanes
lytic” activity was blocked. This requirement for caspase1, 2, 4, and 6) 1 mM N7-Smac/DIABLO peptide. The products were
separated on SDS-PAGE, and the membranes were blotted with 3 activity to produce further cleavage of the p20 frag-
anti-caspase 3 antibody. The full-length procaspase 3 and p20 and
p19 fragments are indicated with arrows. The experiment was per-
formed on two separate occasions and produced similar results.
(C) HeLa cells were transfected on coverslips with 0.5 g GFP- treated with or without grB/AD for 2 hr. Cells were fixed with 4%
expressing or GFP-IETD-Smac-expressing plasmid with () or with- paraformaldehyde in PBS and analyzed by microscopy. Data are
out () 0.5 g Bcl-2-expressing plasmid. After 24 hr, the cells were the mean  SD of four independent experiments.
Immunity
362
ment has been reported previously (Sharif-Askari et al., chondrial released Omi/HtrA2 can enhance apoptosis,
2001). Clearly, the caspase 9 amplification pathway is via its BIR3 binding domain, and also through its serine
dampened in the Bcl-2-transfected cells. However, the protease activity (Hegde et al., 2002; Martins et al., 2002;
critical processing step of caspase 3 from p20 to p19/ Suzuki et al., 2001; Verhagen et al., 2002). Our initial
17 was blocked, thus preventing progression of the apo- observations suggest that Omi, like Smac/DIABLO, can
ptotic program. also overcome Bcl-2 block (data not shown). In addition,
Candidate proteins that may cause such a caspase- the roles of Endonuclease G (Li et al., 2001) and AIF
processing arrest could be members of the IAP family (Susin et al., 1999) have not yet been explored with
of proteins (Holcik and Korneluk, 2001) that bind and respect to the grB death pathway. Although most of our
inhibit the processed forms of caspase 3, 7, and 9 (De- discussion has focused on the mitochondrial involve-
veraux et al., 1997; Srinivasula et al., 2001). In particular, ment mediated by Bid, it is possible that other routes
XIAP binding to caspase 3 occurs preferentially to the to mitochondrial protein release are possible. Notably in
p20 subunit (Deng et al., 2002; Sun et al., 2002), thereby Bid-deficient mice, cytochrome c release is attenuated
inhibiting its further maturation to p19/17 (Li et al., 2002; after granzyme B treatment but death still occurs
Srinivasula et al., 2000). Therefore, we decided to test (Thomas et al., 2001), and this could be due to release
whether XIAP had any effect on the ability of grB to of Smac/DIABLO, Omi, AIF, or Endonuclease G.
generate the active components of caspase 3. In an in In total, our results suggest a two-stage model of
vitro system of grB-dependent caspase 3 activation, caspase activation that involves a direct contribution of
XIAP proved to be a potent inhibitor of caspase 3 pro- grB to create the first cleavage in caspase 3. However,
cessing (Figure 5). The activation profile observed was there is a second, indirect role for the proteinase that
identical to the earlier pattern observed with grB-treated involves cleavage of Bid and effects on the release of
Bcl-2 transfected cells. This suggested that the Bcl-2 mitochondrial proteins. We propose that cytosolic
transfected cells had suboptimal caspase activation be- Smac/DIABLO and Omi/HtrA2 contribute to the grB
cause the presence of XIAP caused a build-up of p20 pathway by relieving the inhibition of IAPs. The coordi-
or more importantly a lack of processing to p19. nated action of these molecules results in the rapid
In order to establish the physiological significance of induction of an efficient apoptotic death program. IAPs
these results, we tested whether overexpression of XIAP and Bcl-2 family members could act to disrupt this coor-
in live cells could attenuate grB-mediated killing. The dinated effort and thus limit lymphocyte-induced killing.
results exactly mirrored what had been observed in the Such molecules have been shown to be overexpressed
in vitro assays. Infection of cells with an adenovirus that in tumors. Perhaps by interfering with their action in
encodes XIAP completely blocked apoptotic cell death vivo it will be possible to re-coordinate the response.
as revealed by TUNEL. This could be explained by inhibi- Alternatively, influencing levels of expression of such
tion of caspase 9 resulting in less caspase 3 activation. molecules may represent an interesting therapeutic tar-
Undoubtedly this occurs, but the critical point was re- get for immunosuppression.
vealed by analysis of the pattern of caspase 3 activation.
The striking feature in the infected cells was the com-
Experimental Procedures
plete blockage of caspase 3 proteolysis at p20, indicat-
ing an effect of XIAP on caspase 3. Cell Lines and Reagents
Other reports show that caspase 3-processing block The human T cell lymphoma line Jurkat and transfected J-Bcl-2
cells were maintained as described previously (Heibein et al., 2000).can be overcome by the protein Smac/DIABLO (Deng
The J-DN-C9 cells were derived by transfecting Jurkat cells with aet al., 2002; Li et al., 2002; Sun et al., 2002). Smac/
plasmid encoding human procaspase 9, C287A. To isolate cellsDIABLO was first identified as a protein that was re-
that overexpressed the dominant-negative protein, we treated theleased from mitochondria after exposure of cells to UV
neomycin-resistant bulk population 2 with anti-Fas antibody (250
(Du et al., 2000; Verhagen et al., 2000). Cytosolic Smac/ ng/ml) and created clonal lines of the surviving cells. The levels of
DIABLO interacts with IAPs and reduces IAP protection DN-C9 expression were assessed by Western blotting, using anti-
(Du et al., 2000; Srinivasula et al., 2001; Verhagen et al., caspase 9 antibody. Three clones were analyzed and showed similar
results. The data presented are from clone 6. HeLa cells were trans-2000). In fact, the N terminus alone of mature Smac/
fected with Lipofectamine 2000 (Invitrogen) according to the manu-DIABLO displaces XIAP from caspase 9 to promote cas-
facturer’s instructions. GrB was purified from the cytolytic granulespase activation in vitro (Srinivasula et al., 2001). Our
of the NK line YT-Indy, as previously described (Caputo et al., 1999).results showed that the N terminus of Smac/DIABLO
Human replication-deficient AD type 5d170-3 was purified from in-
could relieve XIAP suppression of caspase 3 (Figure 6). fected 293 cells, as described (Bett et al., 1994). Caspase 9 antibod-
This suggested that in the in vitro system, caspase 9 ies were from Alexis. Caspase 3 antibodies were a kind gift from
could promote caspase 3 maturation from p20 to p19. Dr. D. Nicholson. Smac/DIABLO antibodies were generously pro-
vided by Drs. M. MacFarlane and G. Cohen. Anti-human Fas IgMIn vivo, however, grB stimulated caspase 3 maturation
antibody (clone CH11) was from Upstate Biotechnology. Immu-even in the presence of DN-C9, implying that in cells the
noblotted proteins were detected using the Enhanced Chemillum-production of mature caspase subunits is autocatalytic.
inescent System (Amersham). The caspase substrates Ac-DEVD-More importantly, however, we show in vivo that overex-
pNA and Ac-LEHD-pNA were from Biomol Research Laboratories.
pression of cytosolic Smac/DIABLO abolished the pro- Smac/DIABLO peptide (NH2-AVPIAQK-COOH) was from the Alberta
tective effect of Bcl-2 on grB-mediated cell death. Peptide Institute.
Therefore, mature Smac/DIABLO alone enabled grB to
bypass the requirement for mitochondrial dysfunction, Cell Death Assays
ultimately allowing cell death. GrB/AD-mediated cell death was carried out as described previously
Other proteins that are released from mitochondria (Motyka et al., 2000). In brief, 1  106 cell/ml were treated with 600
ng of grB and 100 p.f.u. of AD in serum-free media supplementedmay also be involved in the grB death pathway. Mito-
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with 0.1% BSA. The cells were incubated from 2–3 hr at 37C, before the gift of the anti-Smac/DIABLO antibody. This work was supported
by grants from the Canadian Institute of Health Research (CIHR)being harvested and assessed for apoptosis.
Cells killed via the Fas pathway were treated with anti-human Fas and the National Cancer Institute of Canada. R.C.B. is a CIHR Distin-
guished Scientist, a Medical Scientist of the AHFMR, a Howardantibody at 250 ng/ml for 8 hr prior to being harvested and assessed
for apoptosis. Hughes International Scholar, and a Canada Research Chair. M.B.
is an Alberta Heritage Foundation of Medical Research Scholar.
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Received: September 4, 2002Analysis of DNA fragmentation from Jurkat cells by TUNEL has been
Revised: December 20, 2002previously described (Heibein et al., 1999). For HeLa cells, after grB/
AD treatment, the cells were again subjected to trypsin digestion
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